Literature DB >> 7983947

Cost-of-illness studies: fact or fiction?

D P Rice1.   

Abstract

Mesh：

Year:  1994        PMID： 7983947     DOI： 10.1016/s0140-6736(94)90342-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  38 in total

Review 1.  Economic note: cost of illness studies.

Authors:  S Byford; D J Torgerson; J Raftery
Journal:  BMJ       Date:  2000-05-13

2.  Costs of diabetes. A methodological analysis of the literature.

Authors:  E Pagano; M Brunetti; F Tediosi; L Garattini
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

Review 3.  The economic cost of epilepsy: a review.

Authors:  M Brunetti; E Pagano; L Garattini
Journal:  Ital J Neurol Sci       Date:  1998-04

Review 4.  Cost-of-Illness Studies: An Updated Review of Current Methods.

Authors:  Eberechukwu Onukwugha; Jacquelyn McRae; Alex Kravetz; Stefan Varga; Rahul Khairnar; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

5.  Comparing cost-of-illness estimates from alternative approaches: an application to diabetes.

Authors:  Amanda A Honeycutt; Joel E Segel; Thomas J Hoerger; Eric A Finkelstein
Journal:  Health Serv Res       Date:  2009-02       Impact factor: 3.402

6.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

7.  [Impact of early benefit assessment on patients with epilepsy in Germany: Current healthcare provision and therapeutic needs].

Authors:  A Strzelczyk; H M Hamer
Journal:  Nervenarzt       Date:  2016-04       Impact factor: 1.214

8.  An analysis of the influence of framework aspects on the study design of health economic modeling evaluations.

Authors:  Sebastian Gurtner
Journal:  Eur J Health Econ       Date:  2011-11-05

Review 9.  Long term cost-of-illness in stroke: an international review.

Authors:  Krista A Payne; Krista F Huybrechts; J Jaime Caro; Traci J Craig Green; Wendy S Klittich
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

10.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.